Psychiatr Serv 57:1110-1116, August 2006
doi: 10.1176/appi.ps.57.8.1110
© 2006 American Psychiatric Association
Special Section on CATIE Baseline Data |
Substance Use and Psychosocial Functioning in Schizophrenia Among New Enrollees in the NIMH CATIE Study
Marvin S. Swartz, M.D.,
H. Ryan Wagner, Ph.D.,
Jeffrey W. Swanson, Ph.D.,
T. Scott Stroup, M.D., M.P.H.,
Joseph P. McEvoy, M.D.,
Mark McGee, M.D.,
Del D. Miller, M.D.,
Fred Reimherr, M.D.,
Ahsan Khan, M.D.,
José M. Cañive, M.D. and
Jeffrey A. Lieberman, M.D.
OBJECTIVE: This study examined the relationship between substance use and psychosocial functioning in schizophrenia. METHODS: Participants were enrolled in the Clinical Antipsychotic Trials of Intervention Effectiveness. This study used baseline assessments and examined psychosocial functioning assessed by the Quality of Life Scale. Participants were classified as being abstinent, using substances, or having a substance use disorder. RESULTS: Of the 1,460 participants, 23 percent used substances and 37 percent had a substance use disorder. Of the 544 with a substance use disorder, 87 percent used alcohol, 44 percent used marijuana, and 36 percent used cocaine. Compared with participants who used substances, those with a substance use disorder had higher rates of polysubstance use. Compared with those who were abstinent, those who used substances had higher overall psychosocial functioning, and those with a substance use disorder had similar overall functioning but lower scores on the common objects and activities subscales. Among participants with a substance use disorder, those who used cocaine had lower overall functioning. CONCLUSIONS: Compared with abstinence, substance use and substance use disorder, unless they involved cocaine use, were generally associated with higher or equivalent overall psychosocial functioning. Patterns of substance use were similar to those in the community, suggesting that treatment of substance use disorders in schizophrenia should focus on reconnecting substance users to nonusing peer groups.
This article has been cited by other articles:
|
|
|
|
 
N. S. Weber, D. N. Cowan, A. M. Millikan, and D. W. Niebuhr
Psychiatric and General Medical Conditions Comorbid With Schizophrenia in the National Hospital Discharge Survey
Psychiatr Serv,
August 1, 2009;
60(8):
1059 - 1067.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Weisner, Y. Lu, A. Hinman, J. Monahan, R. J. Bonnie, C. D. Moore, F. W. Chi, and P. S. Appelbaum
Substance Use, Symptom, and Employment Outcomes of Persons With a Workplace Mandate for Chemical Dependency Treatment
Psychiatr Serv,
May 1, 2009;
60(5):
646 - 654.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. H. Covell, M. T. Finnerty, and S. M. Essock
Implications of CATIE for Mental Health Services Researchers
Psychiatr Serv,
May 1, 2008;
59(5):
526 - 529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Isaac, P. Chand, and P. Murthy
Schizophrenia outcome measures in the wider international community
The British Journal of Psychiatry,
August 1, 2007;
191(50):
s71 - s77.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Salkever, M. C. Karakus, E. P. Slade, C. M. Harding, R. L. Hough, R. A. Rosenheck, M. S. Swartz, C. Barrio, and A. M. Yamada
Measures and Predictors of Community-Based Employment and Earnings of Persons With Schizophrenia in a Multisite Study
Psychiatr Serv,
March 1, 2007;
58(3):
315 - 324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Swartz, D. O. Perkins, T. S. Stroup, S. M. Davis, G. Capuano, R. A. Rosenheck, F. Reimherr, M. F. McGee, R. S.E. Keefe, J. P. McEvoy, et al.
Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study
Am J Psychiatry,
March 1, 2007;
164(3):
428 - 436.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
